The European Medicines Agency says that Guillain-Barré syndrome should be added as a side-effect in the EU product information for AstraZeneca PLC/Oxford University’s COVID-19 vaccine Vaxzevria, and that adverse events such as lymphadenopathy, tinnitus, diarrhea and vomiting should be listed for the Janssen Pharmaceutical Cos. vaccine.
There are no new safety updates for the other two vaccines approved in the EU – Pfizer Inc./BioNTech...








